Legend Biotech Corporation
LEGN
Classificação em ações
#4512
Legend Biotech Corporation, through its subsidiaries, operates as a... Legend Biotech Corporation, through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe. Its lead product candidate is ciltacabtagene autoleucel, or cilta-cel, which is a chimeric antigen receptor (CAR-T) therapy for the treatment of multiple myeloma (MM). The company also has a portfolio of earlier-stage autologous CAR-T product candidates targeting various cancers, including acute lymphoblastic leukemia, gastric cancer, esophageal cancer, pancreatic cancer, colorectal cancer, small cell lung cancer, and non-small cell lung cancer. In addition, it develops allogeneic gamma delta CAR-T and allogeneic CAR-NK product candidates targeting B-cell maturation antigen (BCMA) for MM, which are in investigator-initiated Phase 1 clinical trials in China. The company has a collaboration and license agreement with Janssen Biotech, Inc. for the development and commercialization of cilta-cel, as well as a license agreement with Novartis Pharma AG for the development, manufacture, and commercialization of CAR-T cell therapies targeting delta-like ligand protein 3. Legend Biotech Corporation was founded in 2014 and is headquartered in Somerset, New Jersey.
Preço da ação
$18.57
Valor de mercado
$3.43B
Variação (1 dia)
0.49%
Variação (1 ano)
-41.90%
País
US
Negociar Legend Biotech Corporation (LEGN)
Categoria
Healthcare
Margem Operacional de Legend Biotech Corporation (LEGN)
Margem Operacional em October 2026 TTM: -4.42%
De acordo com os relatórios financeiros mais recentes e o preço das ações da Legend Biotech Corporation, a margem operacional atual (TTM) é -4.42%. No final de 2023, a margem operacional era -154.13%.
Histórico da Margem Operacional da Legend Biotech Corporation de 2017 a 2026
Margem Operacional no final de cada ano
| Ano | Margem Operacional | Alterar |
|---|---|---|
| 2026 (TTM) | -4.42% | -90.86% |
| 2024 | -48.35% | -68.63% |
| 2023 | -154.13% | -60.44% |
| 2022 | -389.58% | -11.00% |
| 2021 | -437.71% | 5.71% |
| 2020 | -414.06% | 81.18% |
| 2019 | -228.54% | 7,225.00% |
| 2018 | -3.12% | -105.34% |
| 2017 | 58.41% | 0.00% |
Margem Operacional de empresas semelhantes ou concorrentes
| Empresa | Margem Operacional | Diferença na Margem Operacional | País |
|---|---|---|---|
| 38.59% | -108.73% |
US
|
|
| -149.01% | -66.29% |
US
|
|
| 25.57% | -105.79% |
AU
|
|
| 0.00% | - |
CH
|
|
| 28.81% | -106.52% |
NL
|
O que é a Margem Operacional de uma empresa?
A Margem Operacional é um indicador essencial para avaliar a rentabilidade de uma empresa. Margens operacionais mais altas geralmente são melhores, pois mostram que uma empresa consegue vender seus produtos ou serviços por muito mais do que o custo de produzi-los. É calculada dividindo os lucros da empresa pela sua receita.